NARC10 and NARC16, programmed cell death-associated molecules and uses thereof
AssigneeMillennium Pharmaceuticals, Inc.
InventorLillian Wei-Ming Chiang
Life of this patent
Estimating the term…
Loading patent…
AssigneeMillennium Pharmaceuticals, Inc.
InventorLillian Wei-Ming Chiang
Estimating the term…
Novel programmed cell death-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length programmed cell death-related polypeptides, the invention further provides isolated programmed cell death-related fusion proteins, antigenic peptides, and anti-programmed cell death-related antibodies. The invention also provides programmed cell death-related nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a programmed cell death-related gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
An isolated nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of:
An isolated polypeptide comprising an amino acid sequence selected from the group consisting of:
A method for producing a polypeptide selected from the group consisting of:
A method for detecting the presence of a polypeptide in a sample comprising the steps of contacting the sample with a compound that selectively binds to the polypeptide and determining whether the compound binds to the polypeptide in the sample, wherein said polypeptide is selected from the group consisting of:
A kit comprising a compound which selectively binds to a polypeptide and instructions for use, wherein said polypeptide is selected from the group consisting of:
A method for detecting the presence of a nucleic acid molecule in a sample, the method comprising the steps of contacting the sample with a nucleic acid probe that hybridizes to the nucleic acid molecule under stringent conditions, and determining whether the nucleic acid probe binds to a nucleic acid molecule in the sample, wherein said nucleic acid molecule is selected from the group consisting of:
Dependencies are inferred from the claim text.